Nonprofit · EIN 22-2803458
MUSCULOSKELETAL TRANSPLANT FOUNDATION INC
Tax-exempt · EDISON, NJ 08837
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $509,478,090 | $491,143,940 | $18,334,150 | $323,446,458 | $197,128,155 | $126,318,303 |
| December 31, 2023 | 990 | $493,471,813 | $488,670,194 | $4,801,619 | $323,206,971 | $212,992,800 | $110,214,171 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $1,005,875
- Program service revenue
- $495,952,313
- Investment income
- $3,871,279
- Net gain from sales of assets
- $1,260,790
- Net income from sales of inventory
- $898,645
- Other revenue
- $8,648,623
Expenses
- Grants and similar amounts paid
- $1,270,444
- Compensation of officers, directors and key employees
- $5,255,094
- Other salaries and wages
- $114,085,142
- Salaries, compensation and benefits (total)
- $153,355,918
- Professional fundraising fees
- $0
- Legal fees
- $1,197,691
- Accounting fees
- $328,603
- Occupancy
- $11,445,913
- Travel
- $3,615,002
- Depreciation
- $4,697,463
- Program services (functional)
- $446,727,711
- Management and general (functional)
- $44,416,229
Balance sheet and other
- Total assets, start of year
- $323,206,971
- Total assets, end of year
- $323,446,458
- Total liabilities, end of year
- $197,128,155
- Net assets, end of year
- $126,318,303
- Land, buildings and equipment
- $35,169,405
- Net assets without donor restrictions
- $126,318,303
- Gross unrelated business income
- $898,645
- Gross receipts
- $511,923,653
- Employees
- 1,309
- Volunteers
- 14
- Year formed
- 1987
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JOSEPH A YACCARINO | PRESIDENT / CEO Officer | 60 | $901,884 | $56,874 |
| MICHAEL J KAWAS | EXECUTIVE VP/ CFO Officer | 60 | $661,023 | $36,365 |
| MARC LONG | EXECUTIVE VP, R & D Officer | 60 | $494,523 | $63,083 |
| SARAH BRUSCH | EXECUTIVE SPECIALIST - STAR Highest-paid employee | 50 | $476,836 | $71,027 |
| FLOYD VAUGHAN | EXECUTIVE SPECIALIST - STAR Highest-paid employee | 50 | $458,047 | $80,338 |
| JENNIFER BIRMINGHAM | GENERAL COUNSEL Officer | 60 | $477,283 | $56,656 |
| GEORGE HERRERA | EXECUTIVE VP, DONOR SERVICES Key employee | 60 | $456,333 | $75,143 |
| NATHAN RICE | SR. PORTFOLIO MANAGER Highest-paid employee | 50 | $456,446 | $72,356 |
| MICHAEL OLECK | EXECUTIVE VP, PROCESSING Key employee | 60 | $429,512 | $54,512 |
| BRIAN LEUTHNER | VP AND GM PRS FRANCHISE Key employee | 50 | $427,269 | $56,408 |
| KEITH MOROCKO | VP, CONTRACT ADMIN Highest-paid employee | 50 | $406,599 | $75,941 |
| GREGORY ADAMS | NATIONAL SALES DIRECTOR, STAR Highest-paid employee | 50 | $407,106 | $64,570 |
| BRADLEY BAILEY | VP AND GM ORTHO FRANCHISE Key employee | 50 | $379,683 | $51,480 |
| KIMBERLY A ROUNDS | VP WOUND CAR Key employee | 50 | $290,209 | $0 |
| WILLIAM W TOMFORD MD | DIRECTOR Trustee or director | 4 | $75,000 | $0 |
11 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DONALD HACKBARTH MD | CHAIRMAN OF THE BOARD Trustee or director, Officer | 1 | $35,000 |
| DAVID KULBER MD | DIRECTOR Trustee or director | 1 | $31,054 |
| JOSEPH D ZUCKERMAN MD | DIRECTOR Trustee or director | 1 | $30,000 |
| DAVID R MCALLISTER MD | DIRECTOR Trustee or director | 1 | $27,800 |
| JOSEPH A BUCKWALTER MD | DIRECTOR Trustee or director | 1 | $27,500 |
| SHARON GABRIELSON | VICE CHAIR Trustee or director, Officer | 1 | $25,000 |
| JEFFREY P ORLOWSKI | DIRECTOR Trustee or director | 1 | $23,500 |
| MIA TALMOR | DIRECTOR Trustee or director | 1 | $12,000 |
| JAN FINN RN MSN | DIRECTOR Trustee or director | 1 | $0 |
| ALLAN GROSS MD | NON-VOTING DIRECTOR Trustee or director | 1 | $0 |
| GERALD FINERMAN MD | NON-VOTING DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 28 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JOSEPH A YACCARINO | PRESIDENT/CE Officer | 60 | $863,875 | $50,685 |
| MICHAEL J KAWAS | TREASURER/CF Officer | 60 | $673,909 | $33,219 |
| MARC LONG | EXEC R & D Key employee | 60 | $491,568 | $51,235 |
| JENNIFER BIRMINGHAM | SECRETARY/GE Officer | 60 | $487,128 | $51,235 |
| SARAH BRUSCH | SURGICAL CON Highest-paid employee | 50 | $479,204 | $45,010 |
| GEORGE HERRERA | EXEC VP DONO Key employee | 60 | $459,361 | $51,185 |
| MICHAEL OLECK | EXEC VP OPS Key employee | 60 | $454,835 | $42,389 |
| BRIAN LEUTHNER | VP PRS Key employee | 50 | $410,768 | $46,821 |
| AMANDA BLAKEMAN | SURGICAL CON Highest-paid employee | 50 | $402,872 | $40,265 |
| KEITH MOROCKO | VP CONTRACT Highest-paid employee | 50 | $394,947 | $47,933 |
| MICHAEL ROGERS | SURGICAL CON Highest-paid employee | 50 | $409,134 | $28,551 |
| KIMBERLY A ROUNDS | VP WOUND CAR Key employee | 50 | $411,434 | $19,800 |
| BRADLEY BAILEY | VP ORTHOPEDI Key employee | 50 | $384,828 | $44,452 |
| CALEB CHAMBERLAYN | SURGICAL CON Highest-paid employee | 50 | $395,892 | $32,706 |
| MARTHA ANDERSON | FORMER EXEC Former | – | $193,502 | $6,514 |
| THOMAS C SHAFFER | FORMER EXEC Former | – | $169,056 | $8,141 |
| WILLIAM W TOMFORD MD | DIRECTOR Trustee or director | 4 | $75,000 | $0 |
| DONALD HACKBARTH MD | DIRECTOR Trustee or director | 1 | $35,000 | $0 |
| DAVID KULBER MD | DIRECTOR Trustee or director | 1 | $32,250 | $0 |
| JOSEPH D ZUCKERMAN MD | DIRECTOR Trustee or director | 1 | $30,000 | $0 |
| SYMERIA T HUDSON | DIRECTOR Trustee or director | 1 | $28,750 | $0 |
| JOSEPH A BUCKWALTER MD | DIRECTOR Trustee or director | 1 | $27,500 | $0 |
| SHARON GABRIELSON | DIRECTOR Trustee or director | 1 | $25,000 | $0 |
| JAN FINN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ALLAN GROSS MD | NON-VOTING D Trustee or director | 1 | $0 | $0 |
| GERALD FINERMAN MD | NON-VOTING D Trustee or director | 1 | $0 | $0 |
| DAVID R MCALLISTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JEFFREY P ORLOWSKI | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 125 MAY ST, EDISON, NJ 08837-3264
- In care of
- % MICHAEL J KAWAS
- Principal officer (990 for 2024)
- JOSEPH A YACCARINO, 125 MAY STREET, EDISON, NJ 088373264
- Signed the 990
- DEBORAH ALLISON, CHIEF FINANCIAL OFFICER
- Phone
- (732) 661-0202
- Website
- WWW.MTFBIOLOGICS.ORG
- Return prepared by
- GRANT THORNTON ADVISORS LLC
Mission
SEE SCHEDULE O
Program accomplishments
- MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES.IN 2024 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED (SEE SCHEDULE O)ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2024. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS,INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2024, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE.MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS.DURING 2024, MTF MAINTAINED ITS COMMITMENT TO ADVANCING KEY PROGRAMS, WITH SIGNIFICANT INVESTMENTS IN THE FOLLOWING AREAS:TISSUE RECOVERY AND PROCESSING: $203,669,233TISSUE DISTRIBUTION: $228,708,012RESEARCH AND DEVELOPMENT: $15,307,466THESE EFFORTS REFLECT MTF'S ONGOING DEDICATION TO SUPPORTING TISSUE DONATION, ENSURING EFFICIENT DISTRIBUTION, AND DRIVING INNOVATION THROUGH RESEARCH.OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES:1) WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS.2) WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS.3) WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE.4) WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2024, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2024.MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE.FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ DONORS-FAMILIES. STORIESABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ RECIPIENTSExpenses $446,727,711 · grants $1,270,444 · revenue $495,952,313
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 22-2803458
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1996
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E60)
- Assets (IRS master file)
- $323,446,458
- Income (IRS master file)
- $511,923,653
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $509,478,090 | $491,143,940 | $323,446,458 | IRS |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $493,471,813 | $488,670,194 | $323,206,971 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $490,881,944 | $469,345,667 | $324,084,626 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 22-2803458).
Questions about MUSCULOSKELETAL TRANSPLANT FOUNDATION INC
- What is the EIN of MUSCULOSKELETAL TRANSPLANT FOUNDATION INC?
- The employer identification number (EIN) of MUSCULOSKELETAL TRANSPLANT FOUNDATION INC is 22-2803458.
- Is MUSCULOSKELETAL TRANSPLANT FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1996.
- Are donations to MUSCULOSKELETAL TRANSPLANT FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does MUSCULOSKELETAL TRANSPLANT FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of MUSCULOSKELETAL TRANSPLANT FOUNDATION INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did MUSCULOSKELETAL TRANSPLANT FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of MUSCULOSKELETAL TRANSPLANT FOUNDATION INC?
- The 990 for the year ended December 31, 2024 names JOSEPH A YACCARINO.
- Who are the officers and directors of MUSCULOSKELETAL TRANSPLANT FOUNDATION INC?
- The 990 for the year ended December 31, 2024 lists 26 people; 23 received compensation from the organization, the highest $901,884 (JOSEPH A YACCARINO, PRESIDENT / CEO).
- How much revenue does MUSCULOSKELETAL TRANSPLANT FOUNDATION INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $509,478,090, expenses of $491,143,940 and total assets of $323,446,458 at year end.
Other nonprofits in EDISON
- HACKENSACK MERIDIAN HEALTH INC EIN 01-0649794 · last filed 990 for 2024
- FRIENDS OF TEL-AVIV SOURASKY MEDICAL CENTER INC EIN 13-3310053 · last filed 990 for 2024
- BIOCON INC EIN 22-3619257 · last filed 990 for 2024
- CHEVRA HATZOLAH OF MIDDLESEX COUNTY INC EIN 27-1751633 · last filed 990 for 2025
- BIKUR CHOLIM OF RARITAN VALLEY EIN 22-3404037 · last filed 990-EZ for 2025
- MARISA TUFARO FOUNDATION INC EIN 82-1362076 · last filed 990-EZ for 2025
- SUKH SHAM TRUST INC EIN 22-3738262 · last filed 990-PF for 2025
- HEART 2 HUT EIN 46-2618527 · last filed 990-EZ for 2024